A prospective observational study evaluating c-MET expression and EGFR gene mutation correlation with erlotinib response in second line treatment for advanced/metastatic non-small cell lung cancer patients

被引：0
|
作者：
Park, Cheol-Kyu
Choi, Yoo-Duk
Oh, In-Jae
Lee, Jung-Eun
Lee, Shin Yup
Jang, Tae-Won
Ryu, Jeong-Seon
Kim, Young-Chul
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2773
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2773
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combination Effect of Tivantinib with Erlotinib On Cell Proliferation, C-Met Signals and Apoptosis in a Human Non-small Cell Lung Cancer Cell Line
    Koizumi, F.
    Ishii, K.
    Soga, S.
    Akinaga, S.
    Ishida, H.
    Takahashi, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 92 - 93
  • [32] COST-EFFECTIVE ANALYSIS OF ERLOTINIB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER PATIENTS WITH MUTATION OF THE EGFR plus GENE IN COLOMBIA
    Parada Vargas, L. A.
    Barbosa, D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A685 - A686
  • [33] Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer
    Gao, Hong-Fei
    Li, An-Na
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Xie, Zhi
    Zhang, Xu-Chao
    Su, Jian
    Lou, Na-Na
    Yan, Hong-Hong
    Han, Jie-Fei
    Wu, Yi-Long
    CLINICAL LUNG CANCER, 2017, 18 (01) : 85 - 91
  • [34] DETECTING EGFR MUTATION AND ITS LIGANDS EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Wang, S.
    Han, X.
    Li, J.
    Hu, X.
    Wang, X.
    Gui, L.
    Zhao, L.
    Sun, Y.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 394 - 394
  • [35] Associations of C-MET Gene Copy with EGFR Mutation and Gene Copy in EGFR-Tyrosine Kinase Inhibitor (TKI) Untreated Non-Small Cell Lung Cancer (NSCLC)
    Bae, J. M.
    Jeon, Y. K.
    Kim, Y. T.
    Seo, J. W.
    Kim, Y. A.
    Chung, D. H.
    LABORATORY INVESTIGATION, 2010, 90 : 397A - 397A
  • [36] Associations of C-MET Gene Copy with EGFR Mutation and Gene Copy in EGFR-Tyrosine Kinase Inhibitor (TKI) Untreated Non-Small Cell Lung Cancer (NSCLC)
    Bae, J. M.
    Jeon, Y. K.
    Kim, Y. T.
    Seo, J. W.
    Kim, Y. A.
    Chung, D. H.
    MODERN PATHOLOGY, 2010, 23 : 397A - 397A
  • [37] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [38] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [39] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [40] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
12345